Hepatology Communications

Article	Citations
Single‐Cell, Single‐Nucleus, and Spatial RNA Sequencing of the Human Liver Identifies Cholangiocyte and Mesenchymal Heterogeneity	93
Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta‐Analysis	88
Hepatocellular Carcinoma Survival by Etiology: A SEER‐Medicare Database Analysis	82
Effects of Resmetirom on Noninvasive Endpoints in a 36‐Week Phase 2 Active Treatment Extension Study in Patients With NASH	81
Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population	81
Role of Cholesterol‐Associated Steatohepatitis in the Development of NASH	75
Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis	70
Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression	69
Hepatocellular Carcinoma–Circulating Tumor Cells Expressing PD‐L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors	58
Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD	58
Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139‐Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection	58
Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities	56
Clinical Features of Patients With COVID‐19 With Nonalcoholic Fatty Liver Disease	55
The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis	55
Characterization and Proteome of Circulating Extracellular Vesicles as Potential Biomarkers for NASH	52
Coronavirus Disease 2019 in Autoimmune Hepatitis: A Lesson From Immunosuppressed Patients	51
Poor Awareness of Liver Disease Among Adults With NAFLD in the United States	51
The Growing Burden of Disability Related to Nonalcoholic Fatty Liver Disease: Data From the Global Burden of Disease 2007‐2017	50
Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States	48
TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease	48
Hepatic Stellate Cell Regulation of Liver Regeneration and Repair	48
Drug‐Induced Liver Injury in GI Practice	47
Human Nonalcoholic Steatohepatitis on a Chip	42
Fecal Microbiota Transplant in Cirrhosis Reduces Gut Microbial Antibiotic Resistance Genes: Analysis of Two Trials	41
Covid‐19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis	41

Alcohol‐Associated Liver Disease Before and After COVID‐19—An Overview and Call for Ongoing Investigation	40
Liver Care and Surveillance: The Global Impact of the COVID‐19 Pandemic	39
Nonalcoholic Fatty Liver Disease Screening in Type 2 Diabetes Mellitus Patients in the Primary Care Setting	39
SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH	38
A multi‐analyte cell‐free DNA–based blood test for early detection of hepatocellular carcinoma	37
Impact of COVID‐19 in Liver Disease Progression	37
Nonalcoholic Fatty Liver Disease Prevalence Trends Among Adolescents and Young Adults in the United States, 2007‐2016	36
Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta‐analysis	36
Liver Injury in Patients Hospitalized with Coronavirus Disease 2019 Correlates with Hyperinflammatory Response and Elevated Interleukin‐6	36
Exosome‐Like Nanoparticles From Lactobacillus rhamnosus GG Protect Against Alcohol‐Associated Liver Disease Through Intestinal Aryl Hydrocarbon Receptor in Mice	35
Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19	35
Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 Update	35
ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice	33
Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017–2018 transient elastography data and application of machine learning	33
The Impact of COVID‐19 on Organ Donation, Procurement, and Liver Transplantation in the United States	32
Iron overload disorders	32
Direct AMPK Activation Corrects NASH in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis	32
Reduced Clot Stability by Thromboelastography as a Potential Indicator of Procedure‐Related Bleeding in Decompensated Cirrhosis	32
SARS‐CoV‐2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID‐19 Vaccination	31
Breath Metabolomics Provides an Accurate and Noninvasive Approach for Screening Cirrhosis, Primary, and Secondary Liver Tumors	31
Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient‐Reported Outcomes	31
Genome‐Wide Association Study of NAFLD Using Electronic Health Records	30
Hepcidin Signaling in Health and Disease: Ironing Out the Details	29
Recommendations for Implementing Hepatitis C Virus Care in Homeless Shelters: The Stakeholder Perspective	29
High Protein Intake Is Associated With Histological Disease Activity in Patients With NAFLD	28
Pcsk9 Deletion Promotes Murine Nonalcoholic Steatohepatitis and Hepatic Carcinogenesis: Role of Cholesterol	28
Assessment of the Frail Patient With End‐Stage Liver Disease: A Practical Overview of Sarcopenia, Physical Function, and Disability	28
Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients	27
Presence of Liver Inflammation in Asian Patients With Chronic Hepatitis B With Normal ALT and Detectable HBV DNA in Absence of Liver Fibrosis	27
Real‐World Effectiveness of Obeticholic Acid in Patients with Primary Biliary Cholangitis	27
Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case‐Control Study	27
Regorafenib Versus Nivolumab After Sorafenib Failure: Real‐World Data in Patients With Hepatocellular Carcinoma	26
Bile Acid Changes Associated With Liver Fibrosis and Steatosis in the Mexican‐American Population of South Texas	26
Impact of Obeticholic acid Exposure on Decompensation and Mortality in Primary Biliary Cholangitis and Cirrhosis	26
Artificial intelligence-based text generators in hepatology: ChatGPT is just the beginning	26
COVID‐19 Aftershocks on Alcohol‐Associated Liver Disease: An Early Cross‐Sectional Report From the U.S. Epicenter	26
The Growing Burden of Disability Related to Chronic Liver Disease in the United States: Data From the Global Burden of Disease Study 2007‐2017	25
Global and regional long‐term survival following resection for HCC in the recent decade: A meta‐analysis of 110 studies	25
Type IV Collagen 7S Is the Most Accurate Test For Identifying Advanced Fibrosis in NAFLD With Type 2 Diabetes	24
Prevalence and Risk Factors of Advanced Liver Fibrosis in a Population‐Based Study in Germany	24
Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis	24
Distinct Hepatic Gene‐Expression Patterns of NAFLD in Patients With Obesity	24
Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID‐19 Infection	24
Fibrosis‐4 Index as an Independent Predictor of Mortality and Liver‐Related Outcomes in NAFLD	24
Impacts of Early Kasai Portoenterostomy on Short‐Term and Long‐Term Outcomes of Biliary Atresia	24
Current and Emerging Tools for Hepatocellular Carcinoma Surveillance	24
Maralixibat for the treatment of PFIC: Long‐term, IBAT inhibition in an open‐label, Phase 2 study	24
Therapeutic Targeting of Myeloperoxidase Attenuates NASH in Mice	23
Single‐cell transcriptomics reveals conserved cell identities and fibrogenic phenotypes in zebrafish and human liver	23
CMTM6 Stabilizes PD‐L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma	23

Gamma‐Glutamyltransferase Elevation Is Frequent in Patients With COVID‐19: A Clinical Epidemiologic Study	22
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced Liver Disease: An Exploratory Meta‐Analysis	22
Tinospora Cordifolia (Giloy)–Induced Liver Injury During the COVID‐19 Pandemic—Multicenter Nationwide Study From India	22
A Dynamic Aspartate‐to‐Alanine Aminotransferase Ratio Provides Valid Predictions of Incident Severe Liver Disease	22
Dietary Risks for Liver Mortality in NAFLD: Global Burden of Disease Data	22
Associations Between Alcohol Use and Liver‐Related Outcomes in a Large National Cohort of Patients With Cirrhosis	22
Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma	22
Nonalcoholic Fatty Liver Disease Impairs the Liver–Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis	22
Transcriptomic Cross‐Species Analysis of Chronic Liver Disease Reveals Consistent Regulation Between Humans and Mice	22
Deuterium‐Stabilized (R)‐Pioglitazone (PXL065) Is Responsible for Pioglitazone Efficacy in NASH yet Exhibits Little to No PPARγ Activity	22
Functional Microbiomics Reveals Alterations of the Gut Microbiome and Host Co‐Metabolism in Patients With Alcoholic Hepatitis	21
Fecal microbiota transplant improves cognition in hepatic encephalopathy and its effect varies by donor and recipient	21
Urgent Liver Transplantation Soon After Recovery From COVID‐19 in a Patient With Decompensated Liver Cirrhosis	21
Association of Genetic Risk Score With NAFLD in An Ethnically Diverse Cohort	21
Targeted Inhibition of Purine Metabolism Is Effective in Suppressing Hepatocellular Carcinoma Progression	21
Genome‐Wide Association Study of Liver Fat: The Multiethnic Cohort Adiposity Phenotype Study	21
Impact of Metabolic Activity in Hepatocellular Carcinoma: Association With Immune Status and Vascular Formation	20
Hepatocyte TGF‐β Signaling Inhibiting WAT Browning to Promote NAFLD and Obesity Is Associated With Let‐7b‐5p	20
Developmental Programming of NAFLD by Parental Obesity	20
ALT Levels for Asians With Metabolic Diseases: A Meta‐analysis of 86 Studies With Individual Patient Data Validation	20
Predicting Liver‐Related Outcomes in People With Nonalcoholic Fatty Liver Disease: The Prognostic Value of Noninvasive Fibrosis Tests	20
Effect of Omega‐3 Polyunsaturated Fatty Acids on Lipid Metabolism in Patients With Metabolic Syndrome and NAFLD	20
Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET‐NASH Study	20
Risks and Benefits of Discontinuation of Nucleos(t)ide Analogue Treatment: A Treatment Concept for Patients With HBeAg‐Negative Chronic Hepatitis B	20
Immune‐mediated liver injury following COVID‐19 vaccination: A systematic review	20
Hepatic NF‐κB‐Inducing Kinase and Inhibitor of NF‐κB Kinase Subunit α Promote Liver Oxidative Stress, Ferroptosis, and Liver Injury	19
Multiparametric Magnetic Resonance Imaging, Autoimmune Hepatitis, and Prediction of Disease Activity	19
Exploratory Study of Autoantibody Profiling in Drug‐Induced Liver Injury with an Autoimmune Phenotype	19
Innovations in Hepatitis C Screening and Treatment	19
The Detrimental Role of Regulatory T Cells in Nonalcoholic Steatohepatitis	18
Effects of Cirrhosis and Diagnosis Scenario in Metabolic‐Associated Fatty Liver Disease‐Related Hepatocellular Carcinoma	18
Differential Associations of Circulating MicroRNAs With Pathogenic Factors in NAFLD	18
Functionally Diverse Inflammatory Responses in Peripheral and Liver Monocytes in Alcohol‐Associated Hepatitis	18
Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS Study	18
Key Elements on the Pathway to HCV Elimination: Lessons Learned From the AASLD HCV Special Interest Group 2020	18
Favorable impact of long‐term SGLT2 inhibitor for NAFLD complicated by diabetes mellitus: A 5‐year follow‐up study	18
Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease	18
Integrin subunit beta 8 contributes to lenvatinib resistance in HCC	17
Fatty Acid Desaturase 1 Influences Hepatic Lipid Homeostasis by Modulating the PPARα‐FGF21 Axis	17
Racial, Ethnic, and Socioeconomic Disparities in Curative Treatment Receipt and Survival in Hepatocellular Carcinoma	17
Intratumoral Microbiome of Human Primary Liver Cancer	17
Insights from shotgun metagenomics into bacterial species and metabolic pathways associated with NAFLD in obese youth	17
Intestinal virome in patients with alcohol use disorder and after abstinence	17
Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies	17
Elevated Glycated Hemoglobin Is Associated With Liver Fibrosis, as Assessed by Elastography, in a Population‐Based Study of Mexican Americans	17
Primary Treatment with Molecular‐Targeted Agents for Hepatocellular Carcinoma: A Propensity Score‐matching Analysis	17
Nicotinamide Adenine Dinucleotide Metabolome Is Functionally Depressed in Patients Undergoing Liver Transplantation for Alcohol‐Related Liver Disease	17
Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease	16
Pilot Study Using Machine Learning to Identify Immune Profiles for the Prediction of Early Virological Relapse After Stopping Nucleos(t)ide Analogues in HBeAg‐Negative CHB	16
Loss of c‐Jun N‐terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma	16
Impact of Sodium Glucose Cotransporter 2 Inhibitors on Nonalcoholic Fatty Liver Disease Complicated by Diabetes Mellitus	16
What Does the Future Hold for Patients With Nonalcoholic Steatohepatitis: Diagnostic Strategies and Treatment Options in 2021 and Beyond?	16
COVID‐19‐Related Downscaling of In‐Hospital Liver Care Decreased Patient Satisfaction and Increased Liver‐Related Mortality	16
Impact of Aging on Liver Cells and Liver Disease: Focus on the Biliary and Vascular Compartments	16
Interindividual Diversity in Expression of Organic Anion Uptake Transporters in Normal and Cirrhotic Human Liver	16
Combination of tofogliflozin and pioglitazone for NAFLD: Extension to the ToPiND randomized controlled trial	16
Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell–Mediated Antitumor Immunity Through PD‐L1	16
Cluster of Differentiation 44 Promotes Liver Fibrosis and Serves as a Biomarker in Congestive Hepatopathy	16
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC	16
The Exosome‐Associated Tetraspanin CD63 Contributes to the Efficient Assembly and Infectivity of the Hepatitis B Virus	16
Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient‐Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis	16
ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma	15
Liver Injury as a Surrogate for Inflammation and Predictor of Outcomes in COVID‐19	15
Spatial transcriptomics identifies enriched gene expression and cell types in human liver fibrosis	15
High‐Fat Diet Modulates Hepatic Amyloid β and Cerebrosterol Metabolism in the Triple Transgenic Mouse Model of Alzheimer’s Disease	15
Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause from Global Burden of Disease 1990‐2019	15
Serum Bile Acid, Vitamin E, and Serotonin Metabolites Are Associated With Future Liver‐Related Events in Nonalcoholic Fatty Liver Disease	15
Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17‐beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways thro	15
Nonfasted Liver Stiffness Correlates with Liver Disease Parameters and Portal Hypertension in Pediatric Cholestatic Liver Disease	15
Correlation Between Clinical and Pathological Findings of Liver Injury in 27 Patients With Lethal COVID‐19 Infections in Brazil	15
Efficacy of an Inhibitor of Hepatitis B Virus Expression in Combination With Entecavir and Interferon‐α in Woodchucks Chronically Infected With Woodchuck Hepatitis Virus	15
HBcrAg Levels Are Associated With Virological Response to Treatment With Interferon in Patients With Hepatitis Delta	15
Genome‐Wide Association Study of Lean Nonalcoholic Fatty Liver Disease Suggests Human Leukocyte Antigen as a Novel Candidate Locus	15
Type 2 Diabetes: A Risk Factor for Hospital Readmissions and Mortality in Australian Patients With Cirrhosis	14
Distinct responsiveness to rifaximin in patients with hepatic encephalopathy depends on functional gut microbial species	14
Sarcopenia, healthy living, and mortality in patients with chronic liver diseases	14
PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and 68Ga‐PSMA‐11 PET Using Cyclotron‐Produced 68Ga	14
Clinical Staging of Mass‐Forming Intrahepatic Cholangiocarcinoma: Computed Tomography Versus Magnetic Resonance Imaging	14
Clinical phenotype of adult‐onset liver disease in patients with variants in ABCB4 , ABCB11 , and ATP8B1	14
Improving Medication‐Related Outcomes in Chronic Liver Disease	14

Heterozygosity of the Alpha 1‐Antitrypsin Pi*Z Allele and Risk of Liver Disease	14
Loss of Coordinated Neutrophil Responses to the Human Fungal Pathogen, Candida albicans, in Patients With Cirrhosis	14
Ultrasensitive Assay for Hepatitis B Core‐Related Antigen Predicts Hepatocellular Carcinoma Incidences During Entecavir	14
Setting up criteria for drug‐induced autoimmune‐like hepatitis through a systematic analysis of published reports	14
Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis	14
Aiming for Functional Cure With Established and Novel Therapies for Chronic Hepatitis B	14
Linoleic Acid‐Derived Oxylipins Differentiate Early Stage Alcoholic Hepatitis From Mild Alcohol‐Associated Liver Injury	14
Growth hormone deficiency and NAFLD: An overlooked and underrecognized link	13
The Natural History of NAFLD, a Community‐Based Study at a Large Health Care Delivery System in the United States	13
STE20‐Type Protein Kinase MST4 Controls NAFLD Progression by Regulating Lipid Droplet Dynamics and Metabolic Stress in Hepatocytes	13
Serum Matrix Metalloproteinase 7 Is a Diagnostic Biomarker of Biliary Injury and Fibrosis in Pediatric Autoimmune Liver Disease	13
COVID‐19 and the Uncovering of Health Care Disparities in the United States, United Kingdom and Canada: Call to Action	13
Community Socioeconomic Deprivation Predicts Nonalcoholic Steatohepatitis	13
Transcriptional Analysis of Liver Tissue Identifies Distinct Phenotypes of Indeterminate Pediatric Acute Liver Failure	13
Burden of Cirrhosis on Patients and Caregivers	13
Molecular Profiling of Decompensated Cirrhosis by a Novel MicroRNA Signature	12
Direct‐Acting Antiviral Treatment Use Remains Low Among Florida Medicaid Beneficiaries With Chronic Hepatitis C	12
The COVID‐19 Medicine Remdesivir Is Therapeutically Activated by Carboxylesterase‐1, and Excessive Hydrolysis Increases Cytotoxicity	12
Fatty Liver and the Coronavirus Disease 2019 Pandemic: Health Behaviors, Social Factors, and Telemedicine Satisfaction in Vulnerable Populations	12
Automated Measurements of Body Composition in Abdominal CT Scans Using Artificial Intelligence Can Predict Mortality in Patients With Cirrhosis	12
Hepatitis B Virus RNA Profiles in Liver Biopsies by Digital Polymerase Chain Reaction	12
The Selective Peroxisome Proliferator‐Activated Receptor Gamma Modulator CHS‐131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic Steatohepatitis	12
Sex and Menopause Modify the Effect of Single Nucleotide Polymorphism Genotypes on Fibrosis in NAFLD	12
#LiverTwitter: An Emerging Tool for Liver Education and Research	12
Reassessment of the Hispanic Disparity: Hepatic Steatosis Is More Prevalent in Mexican Americans Than Other Hispanics	12
Efficient silencing of hepatitis B virus S gene through CRISPR‐mediated base editing	12
Cellular Location of HNF4α is Linked With Terminal Liver Failure in Humans	12
Primary biliary cholangitis: Epidemiology, prognosis, and treatment	12
High reproducibility of spleen stiffness measurement by vibration‐controlled transient elastography with a spleen‐dedicated module	12
Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo‐Independent Regulation of Heat Shock Protein 70 Family Members	12
National Early Career Transplant Hepatologist Survey: Compensation, Burnout, and Job Satisfaction	12
Establishment of a Cell Culture Model Permissive for Infection by Hepatitis B and C Viruses	12
Outcomes of subjects who are lean, overweight or obese with nonalcoholic fatty liver disease: A cohort study in China	12
Interferon Type I Regulates Inflammasome Activation and High Mobility Group Box 1 Translocation in Hepatocytes During Ehrlichia‐Induced Acute Liver Injury	12
Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab‐based model	12
Risk Associations of Glycemic Burden and Obesity With Liver Cancer—A 10‐Year Analysis of 15,280 Patients With Type 2 Diabetes	12
Secular Trends and Geographic Maps of Hepatitis C Virus Infection among 4 Million Blood Donors in Taiwan from 1999 to 2017	12
An RNA Interference/Adeno‐Associated Virus Vector–Based Combinatorial Gene Therapy Approach Against Hepatitis E Virus	12
Perceptions of Exercise and Its Challenges in Patients With Nonalcoholic Fatty Liver Disease: A Survey‐Based Study	12
Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis	12
Left atrial dysfunction is an independent predictor of mortality in patients with cirrhosis treated by transjugular intrahepatic portosystemic shunt	11
Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease	11
Characteristics and Prognosis of De Novo Hepatocellular Carcinoma After Sustained Virologic Response	11
Antifibrotic effect and long‐term outcome of SGLT2 inhibitors in patients with NAFLD complicated by diabetes mellitus	11
Modeling Outcomes in Children With Biliary Atresia With Native Liver After 2 Years of Age	11
An Experimental DUAL Model of Advanced Liver Damage	11
Hepatic retinoic acid receptor alpha mediates all‐trans retinoic acid's effect on diet‐induced hepatosteatosis	11
Relationship of ELF and PIIINP With Liver Histology and Response to Vitamin E or Pioglitazone in the PIVENS Trial	11
Nonalcoholic Fatty Liver Disease and Associated Risk Factors in a Community‐Based Sample of Mexican‐Origin Adults	11
Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP‐Based Therapy	11
Psychosocial Obstacles to Hepatitis C Treatment Initiation Among Patients in Care: A Hitch in the Cascade of Cure	11
Multispectral Imaging Enables Characterization of Intrahepatic Macrophages in Patients With Chronic Liver Disease	11
Impact of the new definition of metabolic dysfunction–associated fatty liver disease on detection of significant liver fibrosis in US adolescents	11
Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature	11
Evaluation of IL‐6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis	11
Cooperation Between the NRF2 Pathway and Oncogenic β‐catenin During HCC Tumorigenesis	11
Nonalcoholic fatty liver disease prevalence and severity in Asian Americans from the national health and nutrition examination surveys 2017–2018	11
Health‐Related Quality of Life and Its Contributors According to a Preference‐Based Generic Instrument in Cirrhosis	11
The burden of liver cirrhosis and underlying etiologies: results from the Global Burden of Disease Study 2019	11
Enhancing Linkage to Hepatitis C Virus Treatment Following Pregnancy in Women Identified During Perinatal Care	11
Skeletal muscle mass to visceral fat area ratio as a predictor of NAFLD in lean and overweight men and women with effect modification by sex	10
Myeloid Endoplasmic Reticulum Resident Chaperone GP96 Facilitates Inflammation and Steatosis in Alcohol‐Associated Liver Disease	10
Early Allograft Dysfunction Increases Hospital Associated Costs After Liver Transplantation—A Propensity Score–Matched Analysis	10
Unraveling the Relationship Between Itching, Scratch Scales, and Biomarkers in Children With Alagille Syndrome	10
High Effectiveness of Broad Access Direct‐Acting Antiviral Therapy for Hepatitis C in an Australian Real‐World Cohort: The REACH‐C Study	10
Tissue‐Specific Regulation of Ferroportin in Wild‐Type and Hjv‐/‐ Mice Following Dietary Iron Manipulations	10
Molecular Mechanism for Protection Against Liver Failure in Human Yellow Fever Infection	10
Detection of Hepatitis B Virus–Host Junction Sequences in Urine of Infected Patients	10
Impact of long‐term administration of maralixibat on children with cholestasis secondary to Alagille syndrome	10
Prognostic Value of the CLIF‐C AD Score in Patients With Implantation of Transjugular Intrahepatic Portosystemic Shunt	10
Cellular communication network factor 1‐stimulated liver macrophage efferocytosis drives hepatic stellate cell activation and liver fibrosis	10
NAFLD polygenic risk score and risk of hepatocellular carcinoma in an East Asian population	10
Comprehensive Health‐State Utilities in Contemporary Patients With Cirrhosis	10
High‐Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases	10
Oral Zinc Supplementation Decreases the Risk of HCC Development in Patients With HCV Eradicated by DAA	10
Bile acid conjugation deficiency causes hypercholanemia, hyperphagia, islet dysfunction, and gut dysbiosis in mice	10
Elective Surgery but not Transjugular Intrahepatic Portosystemic Shunt Precipitates Acute‐On‐Chronic Liver Failure	10
Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing Cholangitis Develop a Senescence Phenotype Following Biliary Differentiation	10
Body fat composition determines outcomes before and after liver transplantation in patients with cirrhosis	10
A Telephone and Mail Outreach Program Successfully Increases Uptake of Hepatocellular Carcinoma Surveillance	10
Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD	10
Usefulness of the Stroop Test in Diagnosing Minimal Hepatic Encephalopathy and Predicting Overt Hepatic Encephalopathy	10
A prospective investigation of serum bile acids with risk of liver cancer, fatal liver disease, and biliary tract cancer	10
Short‐Term Safety of Repeated Acetaminophen Use in Patients With Compensated Cirrhosis	10
Hepatic Adenosine Triphosphate Reduction Through the Short‐Chain Fatty Acids–Peroxisome Proliferator‐Activated Receptor γ–Uncoupling Protein 2 Axis Alleviates Immune‐Mediated Acute Hepatitis in Inulin	10
Usefulness of Cell‐Free Human Telomerase Reverse Transcriptase Mutant DNA Quantification in Blood for Predicting Hepatocellular Carcinoma Treatment Efficacy	10
Cognitive Impairment and Physical Frailty in Patients With Cirrhosis	10
Bleeding Outcomes Following Transesophageal Echocardiography in Patients With Cirrhosis and Esophageal Varices	10
Development of Alcohol‐Associated Hepatitis Is Associated With Specific Changes in Gut‐Modified Bile Acids	10
The unfolded protein response to PI*Z alpha‐1 antitrypsin in human hepatocellular and murine models	10
Hepatocellular Carcinoma in Hispanic Patients: Trends and Outcomes in a Large United States Cohort	10
A Population‐Based Intervention to Improve Care Cascades of Patients With Hepatitis C Virus Infection	10
Effects of CFTR modulators on serum biomarkers of liver fibrosis in children with cystic fibrosis	10
Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB‐506 from Phase 1 studies in healthy subjects and those with hepatitis B	9
Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus	9